Sam Rodriques, the C.E.O. and co-founder of FutureHouse, discusses the bottlenecks around A.I. drug development, and how Kosmos – the company’s A.I. scientist – aims to solve some of these hurdles and accelerate medical discovery.
Sam Rodriques, the C.E.O. and co-founder of FutureHouse, discusses the bottlenecks around A.I. drug development, and how Kosmos – the company’s A.I. scientist – aims to solve some of these hurdles and accelerate medical discovery.